PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2412571

Immunomodulators and allergy.

G Valcurone·G C Tassi
View original source ↗Export metadata ↓

Abstract

The role played by immunomodulation in allergy is critically reviewed. The prospective mechanisms of immunomodulation, specifically including those showing relation with allergic phenomena, are taken into consideration, examining the main interfering factors. Type I, IgE-mediated immunoreaction, in its two aspects, IgE synthesis and mediator's release, is analyzed, bearing in mind some agents involved or affecting these processes, mimicking immunomodulation. Other agents, such as Corynebacterium granulosum derivatives and glucocorticoids have been also appraised, to highlight their action in this connection.

Explore related subjects

Acetylmuramyl-Alanyl-IsoglutamineAnimalsAnnexinsAntibody SpecificityCalcium Channel BlockersCalmodulinChemotaxis, LeukocyteCimetidineCircadian RhythmCorynebacteriumCromolyn SodiumDrug Administration ScheduleEpitopesGlycoproteinsHLA AntigensHistamineHumansHypersensitivityImmune SystemImmunoglobulin EImmunoglobulin Fc FragmentsImmunotherapyInterferonsKiller Cells, NaturalLeukotriene B4LevamisoleMacrophagesProstaglandinsRanitidineReceptors, ComplementReceptors, Complement 3bSteroidsT-LymphocytesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Valcurone, G C Tassi. 1985. Immunomodulators and allergy.. https://pubmed.ncbi.nlm.nih.gov/2412571/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines.

Maturation is an important process by which dendritic cells (DC) develop the potent antigen-presentation capacity necessary for efficient activation of adaptive immunity. Here, we have investigated the ability of lipoteichoic acid (LTA) and muramyl dipeptide (MDP; the minimal structural unit of peptidoglycan with immunostimulating activity) to induce maturation of human immature DC (iDC), derived from peripheral blood CD14-positive cells, and the production of proinflammatory cytokines. Exposure of iDC to staphylococcal LTA (StLTA) at 1 or 10 microg/ml or MDP at 0.1 or 1 microg/ml alone had little effect on the expression of CD80 and CD83, with a minor increase in expression of CD86, all of which are indicative of cell surface markers for maturation. However, there was a synergistic expression of these molecules when iDC were stimulated with StLTA and MDP together. It is interesting that selective induction of MHC Class II expression was observed during the DC maturation, only when costimulated with LTA plus MDP, and Escherichia coli LPS induced dramatic expression of MHC Classes I and II. Endocytosis assay using Dextran-FITC showed that costimulation with StLTA and MDP attenuated the endocytic capacity of the DC, which is a typical phenomenon of DC maturation. Concomitantly, increased expression of DEC-205, but decreased expression of CD206, was observed under the same costimulating condition. Furthermore, ELISA showed that secretions of TNF-alpha and IL-12 p40, but not IL-10, were induced in iDC by the costimulation. These results suggest that StLTA and MDP synergistically induce maturation and activation of human DC.

Acetylmuramyl-Alanyl-Isoglutamine↗
PubMed2007

NOD protein expression and function in first trimester trophoblast cells.

PROBLEM: Through the expression of pattern recognition receptors, the trophoblast can recognize and respond to infectious microorganisms and, therefore, participate in the control of pathogens that may compromise fetal well-being. We hypothesize that the trophoblast has the ability to sense invasive intracellular bacteria through the cytoplasmic-based nucleotide-binding oligomerization domain (NOD) proteins. The aim of this study was to characterize the expression and function of NOD proteins in first trimester trophoblast cells. METHOD OF STUDY: NOD1 and NOD2 expressions by first trimester trophoblast cells were evaluated by immunohistochemistry, Western blot analysis and reverse transcription-polymerase chain reaction. The effect of NOD2 activation on trophoblast cells was determined by analyzing the cytokine response following treatment with muramyl dipeptide (MDP). RESULTS: Both NOD1 and NOD2 were expressed by first trimester placental villi and localized to trophoblast cells. Moreover, NOD1, NOD2 and the signaling effector protein, RIP-like interacting CLARP kinase (RICK), were all expressed by isolated trophoblast cells. Following exposure to the NOD2 ligand, MDP, trophoblast cells generated a pro-inflammatory cytokine response. This response was confirmed to be specific, as an NOD2-deficient trophoblast cell line failed to respond to MDP unless transfected with NOD2. CONCLUSION: These findings suggest that, through the expression and function of NOD proteins, first trimester trophoblast cells are able to recognize and respond to invasive intracellular pathogens that may have evaded other forms of pattern recognition.

Acetylmuramyl-Alanyl-Isoglutamine↗